Fewer Patients Went to EDs for C difficile Infections in 2024 Compared to 2014
Key Highlights
- Overall ED visits for C. difficile infections decreased by 30% over the decade, indicating progress in infection control.
- Use of metronidazole dropped from 66% to 30%, while vancomycin prescriptions increased by 80%, reflecting updated treatment guidelines.
- Incidence rates among 18-24-year-olds rose by 59%, suggesting changing epidemiology and risk factors.
- More infections are occurring outside hospital settings, pointing to a shift in where and how the infection develops.
- Some ED staff may not be fully adhering to new treatment guidelines, as indicated by continued metronidazole use.

